CSF autoimmune encephalitis panel results
| CSF autoimmune encephalitis panel (ENCEC) | ||
| Result name | Result | Reference value |
| AChR (Muscle) Binding Ab | Positive | Negative |
| NMDA-R Ab CBA | Negative | Negative |
| VGKC-complex Ab IPA | 0.00 nmol/L | 0.00–0.02 |
| LGI1-IgG CBA | Negative | Negative |
| CASPR2-IgG CBA | Negative | Negative |
| GAD65 Ab Assay | 0.00 nmol/L | ≤0.02 |
| GABAB-R Ab CBA | Negative | Negative |
| AMPA-R Ab | Negative | Negative |
| ANNA-1 | Negative | <1:2 |
| ANNA-2 | Negative | <1:2 |
| ANNA-3 | Negative | <1:2 |
| AGNA-1 | Negative | <1:2 |
| PCA-1 | Negative | <1:2 |
| PCA-2 | Negative | <1:2 |
| PCA-Tr | Negative | <1:2 |
| Amphiphysin Ab | Negative | <1:2 |
| CRMP-5-IgG | Negative | <1:2 |
AChR, acetylcholine receptor; AMPA, anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AGNA-1, anti-glial/neuronal antibody type 1; ANNA-1, antineuronal nuclear type 1 antibodies; ANNA-2, antineuronal nuclear type 2 antibodies; ANNA-3, antineuronal nuclear type 3 antibodies; CASPR2, contactin-associated protein 2; CBA, cell-based assay; CRMP-5-IgG, collapsin response-mediator protein-5-IgG; CSF, cerebrospinal fluid; ENCEC, encephalitis panel CSF; GABAB, gamma-aminobutyric acid-B; GAD65, glutamic acid decarboxylase 65; LGI1, leucine-rich glioma inactivated 1; NMDA, anti-N-methyl-D-aspartate; PCA-1, Purkinje cell cytoplasmic type 1 antibodies; PCA-2, Purkinje cell cytoplasmic type 2 antibodies; PCA-Tr, Purkinje cell cytoplasmic type Tr antibodies; VGKC, voltage-gated potassium channel.